| Name | Title | Contact Details |
|---|
Allied Panels is a Mc Farland, WI-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Every day` 119`000 compassionate caregivers serve patients and communities through Providence St. Joseph Health` a national` Catholic` not-for-profit health system` driven by a belief that health is a human right. Rooted in the founding missions of the Sisters of Providence and the Sisters of St. Joseph of Orange` courageous women ahead of their time who brought health care and other social services to the American West when it was still a rugged` untamed frontier` we share a singular commitment to improve the health of all. From our earliest days` we’ve met new challenges by pioneering new solutions. Today` with 51 hospitals` 829 clinics and a comprehensive range of services` we strive to meet the needs of communities across Alaska` California` Montana` New Mexico` Oregon` Texas and Washington through a diverse family of Catholic` other faith-based and mission-driven secular organizations. Now` as we face a new frontier—a changing health care landscape—we draw upon their pioneering and compassionate spirit to plan for the next century of health for a better world` especially for the poor and vulnerable. If you need treatment` please visit www.providence.org to locate a health care provider.
Sullivan Arc Inc is one of the leading providers in Healthcare, Pharmaceuticals, and Biotech. It is based in Monticello, NY. To find more information about Sullivan Arc Inc, please visit www.sullivanarc.org
Ampio is an innovative drug discovery and development company combining scientific, regulatory, and business capabilities to efficiently develop a robust portfolio of novel therapeutic candidates. These therapeutic candidates, if approved, will address significant inflammatory conditions for which limited treatment options exist. Ampio’s therapeutic product pipeline has been developed through more than two decades of study at leading hospital-based research centers. Rigorous preclinical and clinical research efforts have yielded a diverse portfolio of late-stage product candidates focusing on the world’s most prevalent inflammatory conditions including osteoarthritis and diabetic macular edema. Significant discoveries in both basic science and clinical research have resulted in Ampio receiving over 180 patents throughout the world, with hundreds more pending. Further, hundreds of peer-reviewed publications, abstracts, and scientific presentations highlight the depth of research supporting Ampio’s therapeutic product candidates. Ampio’s leading product candidates are Ampion™ and Optina™. The company is currently conducting the second pivotal clinical trial in the US for Ampion, a biologic intra-articular injection being studied for the treatment of osteoarthritis of the knee. Ampio is also conducting a late-stage US clinical trial for Optina, an oral agent being studied for the treatment of diabetic macular edema. Millions of patients worldwide are affected by these conditions, for which limited treatment options exist. At Ampio, we strive to offer compelling therapeutic options for the patients most in need of new treatments, and we operate every day to advance our products’ development and make these available to patients.
Menopause treatment custom to you.